Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01979601 · ClinicalTrials.gov registry record · Phase 1

Safety, Tolerability, PK and PD of LGT209 in Healthy Volunteers and Patients With Hypercholesterolemia

A Phase 1 study of Hypercholesterolemia, sponsored by Novartis Pharmaceuticals.

Completed
Registry status
Phase 1
Development phase
74
Enrollment target
2
Study locations

NCT01979601 is a Phase 1 study of Hypercholesterolemia that has completed, run by Novartis Pharmaceuticals. The registered enrollment target is 74 participants, below the 816-participant average among 62 other Hypercholesterolemia trials with a reported enrollment target (91% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01979601, a Phase 1 study of Hypercholesterolemia, has completed, sponsored by Novartis Pharmaceuticals.

COMPLETED
Registry status
Phase 1
Development phase
74 participants
Enrollment target
2
Study locations

Study Summary

This study is designed to measure the effects of LGT209 when given intravenously to patients with high cholesterol who are on stable doses of statin medications, and to healthy subjects with elevated cholesterol

Conditions Studied

Hypercholesterolemia

Interventions

  • DRUG Placebo
  • DRUG LGT209

Study Locations (2)

Florida

  • Novartis Investigative Site - Miami Gardens

North Dakota

  • Novartis Investigative Site - Fargo

Trial Details

FieldValue
Enrollment Target 74 participants
Start Date 2010-12
Est. Completion 2011-11
Phase Phase 1

Sponsor

Novartis Pharmaceuticals

1,375 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01979601

The ClinicalTrials.gov registry entry for NCT01979601 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 74 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 816-participant average among 62 other Hypercholesterolemia trials with a reported enrollment target (91% lower). The listed sponsor is Novartis Pharmaceuticals, which has 1,375 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hypercholesterolemia appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT01979601 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Florida, North Dakota.

Frequently Asked Questions

What is clinical trial NCT01979601 about?

NCT01979601 is a clinical study titled "Safety, Tolerability, PK and PD of LGT209 in Healthy Volunteers and Patients With Hypercholesterolemia". This study is designed to measure the effects of LGT209 when given intravenously to patients with high cholesterol who are on stable doses of statin medications, and to healthy subjects with elevated cholesterol

What is the current status of trial NCT01979601?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 74 participants. The study started on 2010-12. Estimated completion is 2011-11.

What conditions does trial NCT01979601 study?

This clinical trial studies the following conditions: Hypercholesterolemia.

What interventions are being tested in trial NCT01979601?

The interventions under investigation include: Placebo (DRUG), LGT209 (DRUG).

Who is sponsoring clinical trial NCT01979601?

This trial is sponsored by Novartis Pharmaceuticals, which has 1,375 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01979601 being conducted?

This trial has 2 study locations across Florida, North Dakota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Hypercholesterolemia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Hypercholesterolemia

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.